发明申请
US20100092500A1 NOVEL IMMUNOGENIC LIPOPEPTIDES COMPRISING T-HELPER AND B-CELL EPITOPES
失效
包含T-HELPER和B细胞外膜的新型免疫缺陷型脂蛋白
- 专利标题: NOVEL IMMUNOGENIC LIPOPEPTIDES COMPRISING T-HELPER AND B-CELL EPITOPES
- 专利标题(中): 包含T-HELPER和B细胞外膜的新型免疫缺陷型脂蛋白
-
申请号: US12488485申请日: 2009-06-19
-
公开(公告)号: US20100092500A1公开(公告)日: 2010-04-15
- 发明人: David Jackson , Weiguang Zeng
- 申请人: David Jackson , Weiguang Zeng
- 申请人地址: AU Herston
- 专利权人: The Council of The Queensland Institute of Medical Research
- 当前专利权人: The Council of The Queensland Institute of Medical Research
- 当前专利权人地址: AU Herston
- 主分类号: A61K39/00
- IPC分类号: A61K39/00 ; A61K38/08 ; A61K38/10 ; A61K38/16 ; A61K38/07 ; C07K7/06 ; C07K7/08 ; C07K14/00 ; C07K5/10
摘要:
The present invention provides synthetic immunogenic lipopeptide molecules comprising co-linear T-helper and B cell epitopes, and methods for their production and use in the generation of primary and secondary immune responses, and for the vaccination of animal subjects against particular antigens. More particularly, the present invention provides highly soluble lipopeptides wherein the lipid moiety is attached to the terminal side-chain group of an internal lysine or lysine analog, preferably to the terminal side-chain group of an internal diamino acid residue. Preferably the internal lysine or lysine analog is positioned between the T-helper epitope and the B cell epitope or within the T-helper epitope.
公开/授权文献
信息查询